Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dwight martin who wrote (21972)	6/8/1998 8:48:00 AM
From: Henry Niman	Read Replies (2) of 32384

In San Diego, Robinson also indicated that LGND was making excellent progress in their TZD program. Recently, WLA announced that the NIH diabetes prevention trial had discontinued using Rezulin because of one patient death. Bear Stearns (on Friday) came out with a WLA spot report on the news. They thought that it was odd that the NIH would discontinue Rezulin based on one patient death out of the 600 who had already enrolled. They think that WLA may initiate their own prevention study. They do not expect the FDA to make any changes and consider the NIH reaction as a medical non-event. They expect Rezulin sales to be about $600 million this year and $800 million next year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next